Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1942 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.31 USD | -2.04% | +6.05% | +5.43% | +36.71% | 2.17 B USD | ||
| 1949 | ADMA ADMA Biologics Inc - Common Stock | 9.72 USD | -1.22% | +2.10% | +15.99% | -44.90% | 2.18 B USD | ||
| 1954 | VCEL Vericel Corporation - Common Stock | 42.66 USD | -0.05% | -3.05% | -6.20% | +17.36% | 2.18 B USD | ||
| 1961 | MESO Mesoblast Limited - American Depositary Shares | 16.44 USD | -3.29% | -3.92% | +9.75% | +2.75% | 2.10 B USD | ||
| 1978 | NBTX Nanobiotix S.A. - ADSs | 39.72 USD | -8.79% | +0.28% | -0.10% | +321.66% | 1.92 B USD | ||
| 1979 | ZBIO Zenas BioPharma, Inc. - Common Stock | 31.24 USD | -3.25% | +6.01% | +1.07% | +18.07% | 2.04 B USD | ||
| 1985 | BHVN Biohaven Ltd. Common Shares | 13.74 USD | -0.79% | -4.45% | -6.78% | -18.89% | 2.08 B USD | ||
| 1987 | STOK Stoke Therapeutics, Inc. - Common Stock | 31.75 USD | -1.67% | +1.37% | +7.34% | +62.49% | 2.05 B USD | ||
| 1991 | XNCR Xencor, Inc. - Common Stock | 27.28 USD | -1.87% | +17.28% | +40.04% | +225.54% | 2.03 B USD | ||
| 2008 | ZYME Zymeworks Inc. - Common Stock | 27.30 USD | -4.78% | +8.59% | +18.34% | +53.89% | 1.94 B USD | ||
| 2018 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.19 USD | -3.19% | +0.94% | +10.44% | -10.13% | 1.92 B USD | ||
| 2020 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.87 USD | -3.61% | -2.33% | +3.71% | +95.67% | 1.91 B USD | ||
| 2026 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.07 USD | -0.06% | -0.87% | -8.72% | -23.78% | 1.97 B USD | ||
| 2045 | IMCR Immunocore Holdings plc - American Depositary Shares | 36.04 USD | -2.28% | +5.91% | +2.80% | +7.65% | 1.86 B USD | ||
| 2054 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -5.71% | +6.11% | +8.55% | -34.00% | 1.77 B USD | ||
| 2057 | SEPN Septerna, Inc. - Common Stock | 40.34 USD | +0.85% | -9.96% | +21.32% | +83.28% | 1.88 B USD | ||
| 2077 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.40 USD | -3.43% | +4.20% | +12.01% | -9.62% | 1.74 B USD | ||
| 2098 | GHRS GH Research PLC - Ordinary Shares | 27.45 USD | -3.11% | -6.41% | -1.47% | +93.86% | 1.70 B USD | ||
| 2099 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.26 USD | -1.98% | -2.28% | -8.68% | +18.45% | 1.72 B USD | ||
| 2103 | FTRE Fortrea Holdings Inc. - Common Stock | 18.27 USD | -0.65% | +4.70% | -6.36% | +119.06% | 1.74 B USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |